Loading...
INDEX: NASDAQ
SYMBOL: ACAD
NAME: ACADIA Pharmaceuticals Inc.
UPVOTES: 73
DOWNVOTES: 67


Description

ACADIA Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines for central nervous system disorders. The Company's lead drug candidate, NUPLAZID (pimavanserin), is under development for the treatment of Parkinson's disease psychosis (PDP). NUPLAZID is a selective serotonin inverse agonist (SSIA), targeting 5-HT2A receptors. The Company's Pimavanserin is a chemical entity, which has completed Phase III development, and is indicated for the treatment of Parkinson's disease psychosis. NUPLAZID (pimavanserin) is a selective serotonin inverse agonist preferentially targeting the 5-HT2A receptor, a key serotonin receptor that plays a role in psychosis. Through this mechanism, NUPLAZID has demonstrated efficacy in Parkinson's disease psychosis in its Phase III pivotal trial and avoids the side effects of existing antipsychotics.

Read Full Descript at Reuters

ACAD Message Board



Todays Most
Up-Voted
Todays Most
Down-Voted
Most
Recent Voted
All Time Most
Up-Voted
All Time Most
Down-Voted
Top
Voted Index

NASDAQ



Stock SymbolUp VotesDown VotesVote
ACB30
ARCB20
AUMN10
AMER21
ALQA10
ADMS10
ACET11
APAFF01
AREX01
AIM01
Stock SymbolUp VotesDown VotesVote
TSLA319106
CBIS306131
AMD288221
DIS15896
NVDA14489
AMZN15299
KTOS12781
NFLX12685
MSRT13091
NAT9661
Stock SymbolUp VotesDown VotesVote
ALIM52
AGNC63
ACB52
ARCB63
TKSTF31
AMDA42
AXS53
ATTBF42
AMER53
ACAD42
Stock SymbolUp VotesDown VotesVote
SDVI189
AGNC126
ARCB1410
AAPL128
ALIM85
ACAD85
A96
QSEP63
AXS108
IPG31
Stock SymbolUp VotesDown VotesVote
TSLA319106
CBIS306131
AMD288221
DIS15896
NVDA14489
AMZN15299
KTOS12781
NFLX12685
MSRT13091
NAT9661

Last 10 Stocks Voted On

Stock SymbolActionVote
ACETUPVOTE
AMERDOWNVOTE
AMERUPVOTE
ACETDOWNVOTE
AGMDOWNVOTE
AETDOWNVOTE
ARCBUPVOTE
ALQAUPVOTE
ARCBUPVOTE
ACBUPVOTE